MedTrace Logo

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

NCT06020807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2023-09-07

No results posted yet for this study

Summary

This is a prospective study to establish the analytical specificity of Bladder EpiCheck test in urine samples from healthy population and urology patients without prior history or evidence of bladder cancer.

Conditions

  • Non Muscle Invasive Bladder Cancer
  • Non-Muscle Invasive Bladder Urothelial Carcinoma

Interventions

DIAGNOSTIC_TEST

Bladder EpiCheck

Bladder EpiCheckTM (EpiCheck) is a urine test for monitoring of recurrence of NMIBC based on analysis of 15 informative DNA methylation biomarkers.

Sponsors & Collaborators

  • Nucleix Ltd.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-05
Primary Completion
2020-01-08
Completion
2020-01-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06020807 on ClinicalTrials.gov